Paul Lock – Chairman & Managing Director – Pan Asia Metals (PAM) is a minerals exploration and development company with tungsten and lithium projects located in southern Thailand.
Copyright 2023 – Finance News Network
Source: Finance News Network
29 Jul 2021 - BARD1 Life Sciences Limited (ASX:BD1) CEO Dr Leearne Hinch introduces the company, discussing its recent capital raising and share purchase plan.
Read More03 Mar 2025 - Addressing Unmet Needs in Cancer Care
Read More14 Jun 2023 - Australia holds the world's third largest amount of vanadium, behind China and Russia, but does not supply this critical mineral into the global market. Project Director Peter Hedley from Richmond Vanadium Technology (ASX:RVT) discusses the company's progress and the vanadium industry.
Read More09 Feb 2024 - QX Resources Limited (ASX:QXR) Managing Director Steve Promnitz discusses movements in the lithium price and recent drill results.
Read More08 Jun 2021 - Danakali Limited (ASX:DKM) Executive Chairman Seamus Cornelius discusses the company's Colluli project, including financing and economics, and the positive impact of the project on the region.
Read More23 Sep 2019 - SUDA Pharmaceuticals Limited (ASX:SUD) Managing Director & CEO, Stephen Carter discusses the company's portfolio and the benefits of reformulating and delivering medication through the oral mucosa.
Read More16 Nov 2023 - Linius Technologies Limited (ASX:LNU) CEO and Executive Director James Brennan discusses the company's quarterly performance and its technology for rendering video files as flexible as other forms of data.
Read More11 Dec 2020 - Cyclopharm Limited (ASX:CYC) CEO & Managing Director James McBrayer talks about USFDA approval for Technegas, the company's USA commercialisation plan, and opportunities beyond its key diagnostic market for pulmonary embolism.
Read More21 Aug 2020 - DigitalX Limited (ASX:DCC) Executive Director Leigh Travers provides an update on the company's strategy, its focus on blockchain consulting and development for the enterprise market and digital asset management, the impact of COVID-19, and priorities.
Read More19 Aug 2024 - Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt discusses progress with the company's IMP761 drug, which is potentially active in more than 90% of autoimmune diseases.
Read More
